Sinopharm Group Co. Ltd.
SHTDFOTCHealthcare● Active
$2.30
+$0.01(+0.44%)
Market Cap$7.2B
P/E Ratio—
52W High$2.7
52W Low$2.11
Sinopharm Group Co. Ltd.（SHTDF）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SHTDF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $14.80B | $14.00B | $19.51B | $18.56B | $17.00B |
| Depreciation & Amort. | $4.29B | $4.73B | $4.43B | $4.17B | $3.92B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($2.75B) | ($13.24B) | ($3.86B) | ($2.07B) | ($12.10B) |
| Net Cash from Operations | $14.14B | $11.55B | $17.17B | $20.96B | $9.31B |
| Investing Activities | |||||
| Capital Expenditure | ($1.62B) | ($1.97B) | ($2.34B) | ($2.42B) | ($2.26B) |
| Purchases of Investments | $0.00B | $0.00B | ($0.03B) | ($0.10B) | ($0.07B) |
| Sales of Investments | $0.02B | $0.00B | $0.05B | $0.21B | $0.30B |
| Net Cash from Investing | ($0.96B) | ($3.75B) | ($0.94B) | ($3.59B) | ($1.27B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($2.12B) | ($2.71B) | ($2.56B) | ($2.34B) | ($2.15B) |
| Debt Issued / Repaid | ($10.91B) | ($9.94B) | $2.50B | $4.75B | ($4.79B) |
| Net Cash from Financing | ($18.69B) | ($17.29B) | ($7.64B) | ($5.69B) | ($14.69B) |
| Free Cash Flow | |||||
| Free Cash Flow | $12.52B | $9.58B | $14.84B | $18.55B | $7.05B |
| FCF Margin %(computed) | 2.23% | 1.64% | 2.49% | 3.36% | 1.35% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · CNY · B
深入了解Sinopharm Group Co. Ltd.
关于Sinopharm Group Co. Ltd.（SHTDF）现金流量表
Sinopharm Group Co. Ltd. 2025财年经营活动现金流$14.14B，自由现金流$12.52B（FCF利润率2.23%），资本支出($1.62B)。
常见问题
SHTDF · 4 问Sinopharm Group Co. Ltd. 2025财年自由现金流$12.52B，同比up30.7%。
SHTDF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10